Anti-Abortion Advocacy Groups’ Challenge to FDA-Approved Abortion Pill May Have Far-Reaching Consequences
Health Law Advisor
JANUARY 30, 2023
Food and Drug Administration (“FDA”) to withdraw approval of Mifepristone, an FDA-approved drug used to end pregnancies in the first trimester. [1] The lawsuit has sparked concern by both industry and the FDA. abortions, according to the Guttmacher Institute. [2] abortions, according to the Guttmacher Institute. [2]
59 
Let's personalize your content